{
    "clinical_study": {
        "@rank": "23195", 
        "arm_group": [
            {
                "arm_group_label": "ramosetron 0.3 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "preparation of ramosetron 0.3 mg"
            }, 
            {
                "arm_group_label": "ondansetron 8 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "preparation of ondansetron 8mg"
            }, 
            {
                "arm_group_label": "ondansetron 4 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "preparation of ondansetron 4mg"
            }, 
            {
                "arm_group_label": "non 5-HT3 receptor antagonist", 
                "arm_group_type": "Placebo Comparator", 
                "description": "preparation of  normal saline 5 ml"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to estimate effects of different kinds, different dose of\n      5-HT3 receptor antagonists on prevention of hypotension after spinal anesthesia"
        }, 
        "brief_title": "Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypotension", 
            "Shivering", 
            "Nausea and Vomiting", 
            "Vasopressor"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypotension", 
                "Vomiting"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing spinal anesthesia\n\n        Exclusion Criteria:\n\n          -  hypersensitivity on 5-HT3 receptor antagonists hypertension cardiovascular disease\n             intake of selective serotonin reuptake inhibitor"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669213", 
            "org_study_id": "WSAhn_ramosetron_hypotension"
        }, 
        "intervention": [
            {
                "arm_group_label": "ramosetron 0.3 mg", 
                "description": "before 5 minutes spinal anesthesia, injection of ramosetron 0.3 mg", 
                "intervention_name": "ramosetron", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ondansetron 8 mg", 
                "description": "before 5 minutes spinal anesthesia, injection of ondansetron 8 mg", 
                "intervention_name": "ondansetron", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ondansetron 4 mg", 
                "description": "before 5 minutes spinal anesthesia, injection of ondansetron 4 mg", 
                "intervention_name": "ondansetron", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "non 5-HT3 receptor antagonist", 
                "description": "before 5 minutes spinal anesthesia, injection of normal saline 5 ml", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Ondansetron", 
                "Ramosetron"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "5-HT3 receptor antagonist", 
            "hypotension", 
            "spinal anesthesia"
        ], 
        "lastchanged_date": "August 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension After Spinal Anesthesia", 
        "other_outcome": {
            "measure": "occurrence ratio of shivering, nausea and vomiting, and usage doses of vasopressor (ephedrine or phenylephrine), and atropine", 
            "safety_issue": "No", 
            "time_frame": "up to 30 min after spinal anesthesia"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "comparasion of significantly difference in the gap between baseline mean arterial pressure and lowest mean arterial pressure measured during 30 minutes after spinal anesthesia.", 
            "measure": "prevention of hypotension by calcaulation the gap between baseline mean arterial pressure and lowest mean arterial pressure measured during 30 minutes after spinal anesthesia.", 
            "safety_issue": "No", 
            "time_frame": "up to 30mins after spinal anesthesia"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669213"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Wonsik Ahn", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "comparasion of significantly difference in the gap between baseline systolic arterial pressure and lowest systolic  arterial pressure measured during 30 minutes after spinal anesthesia and the gap between baseline diastolic arterial pressure and lowest diastolic arterial pressure measured during 30 minutes after spinal anesthesia.", 
            "measure": "prevention of hypotension bycalculation the gap baseline systolic and diastolic blood pressure and lowerst systolic and diastolic blood pressure", 
            "safety_issue": "No", 
            "time_frame": "up to 30mins after spinal anesthesia"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}